ALDX Quote, Trading Chart, Aldeyra Therapeutics Inc.
home / stock / aldx / aldx quote
$11.17 Last:
-6.21% Change Percent:
$11.79 Open:
$11.17 Previous Close:
$12.12 High:
$10.76 Low:
772,451 Volume:
03/04/2021 04:55:14 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-04 | 11.79 | 11.17 | 12.12 | 10.76 | 772,451 |
| 2021-03-03 | 12.32 | 11.91 | 12.6 | 11.71 | 551,617 |
| 2021-03-02 | 12.3 | 12.43 | 12.5 | 11.8 | 612,312 |
| 2021-03-01 | 12.39 | 12.2 | 12.83 | 11.94 | 513,937 |
| 2021-02-26 | 11.69 | 12.26 | 12.33 | 11.35 | 512,659 |
| 2021-02-25 | 12.22 | 11.7 | 12.33 | 11.4783 | 626,710 |
| 2021-02-24 | 12.01 | 12.22 | 12.58 | 11.55 | 711,048 |
| 2021-02-23 | 11.74 | 11.38 | 11.75 | 10.55 | 950,423 |
| 2021-02-22 | 12.54 | 12.19 | 13.07 | 12.08 | 592,363 |
| 2021-02-19 | 12.64 | 12.75 | 13.35 | 12.5201 | 604,219 |
| 2021-02-18 | 13.32 | 12.35 | 13.49 | 12.2 | 1,006,501 |
| 2021-02-17 | 14.08 | 13.2 | 14.3299 | 12.53 | 1,659,287 |
| 2021-02-16 | 13 | 14.42 | 14.52 | 12.77 | 3,556,651 |
| 2021-02-15 | 11.97 | 12.7 | 13.19 | 11.62 | 1,131,840 |
| 2021-02-12 | 11.97 | 12.7 | 13.19 | 11.62 | 1,131,103 |
| 2021-02-11 | 11.9 | 11.83 | 12.3 | 11.48 | 626,379 |
| 2021-02-10 | 12.01 | 11.66 | 12.5 | 11.55 | 672,279 |
| 2021-02-09 | 12.503 | 12 | 12.6178 | 11.85 | 1,125,286 |
| 2021-02-08 | 13 | 12.24 | 13.2 | 12.18 | 1,546,098 |
| 2021-02-05 | 12.2 | 12.59 | 12.75 | 12.06 | 931,343 |
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, March 11, 2021 to report financial results for the year ended December 31, 2020 and discuss recent business highlights. The dial-in numbers are (866) 211-4098 for domestic c...
-
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will present at the 10th Annual SVB Leerink Global Healthcare Conference at 3:40 p.m. ET Friday, February 26, 2021. A live webcast of the p...
-
TRANQUILITY to Utilize Two-Day Treatment and Challenge Design Consistent with Previously Announced Top-Line TRANQUILITY Run-In Cohort Results, Ocular Redness Selected as Primary Endpoint Tear RASP Levels Reduced After Single Doses of Reproxalap in Run-In Cohort of TRANQUILITY ...